VOR BIOPHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.8 USD | +3.45% |
|
-2.70% | -20.00% |
| 13/05 | Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating | MT |
| 09/05 | Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 12Cr | - | - | - | - | - | |
| 4.95TCr | - | |||||
| 4.26TCr | ||||||
| 4.25TCr | ||||||
| 2.91TCr | ||||||
| 2.66TCr |
- Stock Market
- Equities
- VOR Stock
- Charts Vor Biopharma Inc.
- Sector Chart